Q/C TECHNOLOGIES, INC. — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2016-01-05

Reporting Person: AKERS RAYMOND FRANCIS JR (Director, Executive Chairman, Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-05	Common Stock	P	2100	$1.34	Acquired	72100	Indirect

Footnotes

F1: Dr. Akers previously gifted 70,000 shares of Common Stock to the Akers Family Trust, a trust to which he is not a named beneficiary.

F2: On January 5, 2016, Dr. Akers' wife purchased 2,100 shares of Common Stock.